期刊文献+

B型利钠肽在评估慢性房颤患者左心房血栓形成的价值 被引量:4

Clinical significance of B-type natriuretic peptide in the evaluation of left atrial thrombus for patients with chronic atrial fibrillation
下载PDF
导出
摘要 目的:探讨B型利钠肽(BNP)在评估慢性房颤患者左心房血栓形成中的临床价值。方法:对65例慢性房颤患者实施经食管超声检查,根据有无左心房血栓分组,检测并比较患者的BNP及其他临床资料。结果:左房血栓组的血浆BNP水平高于无左房血栓组(93.27±22.13)ng/L对(54.19±19.04)ng/L。多变量回归分析表明,高血浆BNP水平是慢性房颤患者发生左房血栓的独立预测指标(OR=1.01,95%CI:1.00~1.15,P=0.04)。结论:血浆BNP水平可作为预测慢性房颤患者左房血栓的指标。 Objective: This study aims to examine the clinical value of B-type natriuretic peptide (BNP)for left atrial thrombosis in patients with chronic atrial fibrillation. Methods: A total of 65 patients with chronic atrial fibrillation were divided into two groups according to left atrial thrombosis by transesophageal echocardiography (TEE). Plasma levels of BNP and other clinical data were recorded and analysed. Results: Thirty-one patients had left atrial thrombus (LAT) by TEE. Baseline characteristics in patiens with LAT (positive group ) and those without LAT (negative group) were similar. Mean BNP levels were significantly higher in positive group than negative group [(93. 27 ± 22.13) ng/L vs. (54. 19 ± 19. 04) ng/L, P 〈 0. 05]. Multivariate logistic regression analysis demonstrated that BNP level was a predictor for LAT independent of the left atrial diameter (OR = 1.0l, 95%CI: 1. 00 - 1. 15, P = 0. 04), as well as CHADS2 scores. Conclusion: BNP levels predict independently left atrial thrombosis in patiens with chronic atrial fibrillation.
出处 《国际心血管病杂志》 2013年第2期122-123,共2页 International Journal of Cardiovascular Disease
关键词 B型利钠肽 心房颤动 左房血栓 B-type natriuretic peptide Atrial fibrillation Left atrial thrombus
  • 相关文献

参考文献6

  • 1European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, et al. Guidelines for the management of atrial fibrillation., the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2010, 31 (19): 2369-2429. 被引量:1
  • 2Deftereos S, Giannopoulos G, Kossyvakis C, et al. Estimation of atrial fibrillation recency of onset and safety of cardioversion using NTproBNP levels in patients with unknown time of onset[J]. Heart,2011,97(11) :914-917. 被引量:1
  • 3Patton KK, Ellinor PT, Heckbert SR, et al. N-terminal pro- Btype natriuretic peptide is a major predictor of the development of atrial fibrillation: the Cardiovascular Health Study[J]. Circulation,2009,120(18) : 1768-1774. 被引量:1
  • 4Hijazi Z, Oldgren J, Andersson U, et al. Cardiac hiomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long term Antieoagulation Therapy (RE-LY) substudy[J]. Circulation, 2012,125(13) : 1605-1616. 被引量:1
  • 5Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation[J]. Chest, 2010, 137(2) : 263-272. 被引量:1
  • 6Fang MC, Go AS, Chang Y, et al. Comparison of risk stratification schemes to predict thromboembolism in people with nonvalvular atrial fibrillation[J]. J Am Coll Cardiol, 2008,51(8) :810-815. 被引量:1

同被引文献45

  • 1王华,杨杰孚,张传宝,包承鑫,胡云建,褚德发,钟优,李宏义,张瑞生,刘德平,曾学寨.慢性心力衰竭患者凝血功能及C反应蛋白的改变[J].中国循环杂志,2006,21(3):178-181. 被引量:8
  • 2刘兴鹏,马长生.心房颤动治疗的整体策略与非药物治疗措施的地位[J].心血管病学进展,2006,27(5):554-556. 被引量:10
  • 3国际心脏病学会和协会及世界卫生组织临床命名标准化联合专题组.缺血心脏病的命名及诊断标准[J].中华心血管病杂志,1981,9(1): 75. 被引量:7
  • 4Vemmos KN ,Takis CE, Georgilis K, et al. The Athens stroke registry : results of a five-year hospital-based study [ J ]. Cere- brovasc Dis,2000,10(2) : 133 - 141. 被引量:1
  • 5Sohara H, Amitanis S, Kurose M, et al. Atrial fibrillation ac- tivates platelets and coagulation in a time-dependent man- ner: a study in patients with paroxysmal atrial fibrillation [J]. J Am Cdl Cardiol, 1997,29( 1 ) :106 - 112. 被引量:1
  • 6Shimizu H, Murakami Y, Inoue S, et al. High plasma brain natriumtic polypeptide level as a marker of risk for thrombo- embolism in patiems with nonvalvular atrial fibrillation[ J ]. Stroke,2002,33(4) :1 005- 1 010. 被引量:1
  • 7Qaseem A, Fihn SD, Williams S, et al. Diagnosis of stable ischemic heart disease: summary of a clinical practice guideline from the American College of physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/ preventive Cardiovascular Nurses Association Society of Thoracic Surgeons ~J~. Ann Intern Med, 2012, 157 (10): 729-734. 被引量:1
  • 8Bonow RO, Mann DL , Zipes DP, et al. Braunwald' s Heart Disease: a textbook of cardiovascular medicine[M~. 9 th ed. Philaelephia, PA: Saunders Elsevier, 2012..1251. 被引量:1
  • 9Massie BM, Krol WF, Ammon SE, et al. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics [J~. JCard Fail,2004, 10(2) : 101-112. 被引量:1
  • 10Cleland JG, Findlay I, Jafri S, et al. The Warafrin/Aspirin Study in Heart Failure (WASH): a randomized trial comparing antithrombotic strategies for patents with heart failure[J]. Am Heart J,2004, 148(1) 157-164. 被引量:1

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部